Page last updated: 2024-11-01

o(6)-benzylguanine and Digestive System Neoplasms

o(6)-benzylguanine has been researched along with Digestive System Neoplasms in 1 studies

O(6)-benzylguanine: a suicide inhibitor of O(6)-methylguanine-DNA methyltransferase activity

Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.

Research Excerpts

ExcerptRelevanceReference
"Early phase evaluation of anticancer drugs has traditionally used toxicity (usually hematological) rather than efficacy end points to establish appropriate dosing schedules."2.69O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. ( Gerson, SL; Haaga, J; Hoppel, CL; Ingalls, ST; Liu, L; Majka, S; Pluda, JM; Spiro, TP; Willson, JK, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spiro, TP1
Gerson, SL1
Liu, L1
Majka, S1
Haaga, J1
Hoppel, CL1
Ingalls, ST1
Pluda, JM1
Willson, JK1

Trials

1 trial available for o(6)-benzylguanine and Digestive System Neoplasms

ArticleYear
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
    Cancer research, 1999, May-15, Volume: 59, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Biopsy; Biotransformation; Breast Neoplasms; Carmust

1999